Cargando…
Enhancement of Scaffold In Vivo Biodegradability for Bone Regeneration Using P28 Peptide Formulations
The field of bone tissue engineering has shown a great variety of bone graft substitute materials under development to date, with the aim to reconstruct new bone tissue while maintaining characteristics close to the native bone. Currently, insufficient scaffold degradation remains the critical limit...
Autores principales: | Azaman, Farah Alwani, Brennan Fournet, Margaret E., Sheikh Ab Hamid, Suzina, Zawawi, Muhamad Syahrul Fitri, da Silva Junior, Valdemiro Amaro, Devine, Declan M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10304976/ https://www.ncbi.nlm.nih.gov/pubmed/37375823 http://dx.doi.org/10.3390/ph16060876 |
Ejemplares similares
-
Monitoring In Vitro Extracellular Matrix Protein Conformations in the Presence of Biomimetic Bone-Regeneration Scaffolds Using Functionalized Gold-Edge-Coated Triangular Silver Nanoparticles
por: Rodriguez Barroso, Laura G., et al.
Publicado: (2022) -
Bioresorbable Chitosan-Based Bone Regeneration Scaffold Using Various Bioceramics and the Alteration of Photoinitiator Concentration in an Extended UV Photocrosslinking Reaction
por: Azaman, Farah Alwani, et al.
Publicado: (2022) -
The Value of H3K27me3 Immunohistochemistry in Differentiating Malignant Peripheral Nerve Sheath Tumour with Its Histologic Mimickers
por: Mustapar, Nurulhasanah, et al.
Publicado: (2020) -
The Values of Receptor Activator Nuclear Kappa-B Ligand Expression in Stage III Giant Cell Tumor of the Bone
por: Ghani, Sabrina Abdul, et al.
Publicado: (2018) -
Evaluation of the Receptor Activator of Nuclear Factor Kappa B Ligand (RANKL) Expression in Osteosarcoma and Its Association with the Clinicopathological Data
por: Chua, Hui Heng, et al.
Publicado: (2021)